Trial Profile
The effect of Monthly ibandronate iv injected on the low-responders to pre-existing oral BP treatment for the osteoporosis patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2020
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary) ; Alendronic acid; Minodronic acid; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms MOVEMENT
- 05 Mar 2019 Status changed from active, no longer recruiting to completed.
- 03 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 30 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.